So maybe this is exactly what Missling is referring to when he states "you'll know why we did it the way we did it after we do it" or whatever that quote is that he has used multiple times in the past?
The FDA can approve an NDA (New Drug Application) with one successful P3 trial and the repurposing of an FDA-approved drug. So, if the FDA approves A2-73 for Rett, that would qualify for the first half of our Alzheimer's application. The other half would be our P2b/3 AD trial. IMO, this is the main reason why Anavex wants the FDA to approve Rett first. Once it is approved, they can expedite the entire process for our Alzheimer's application. (Qualifying for the $100M voucher is a bonus) Our FDA guys know what they're doing...especially Dr. Jin. I'm just sitting back and enjoying the ride. smile Cheers.